Category: Issue 289

  • FDA Seeks Comments on Listeria Risk Assessment

    FDA has published a notice requesting comments, scientific data and information “that would assist the agency in its plans to conduct a risk assessment of the public health impact of foodborne Listeria monocytogenes in some ready-to-eat foods, sliced, prepared, and/or packaged in retail facilities.” According to the notice, “[l]ittle is known about how Listeria contamination occurs…

  • Net Health Effects of Commercial Fish Consumption Topic of New FDA Risk Assessment

    FDA this week published a draft assessment weighing the risks and benefits of fish consumption for children and the general population. The assessment considers the net health effects of fish consumption on fetal neurodevelopment, as well as fatal heart disease and stroke risk in the general population. FDA is seeking “to understand the relationship between…

  • FDA Issues Final Guidance on Regulating GE Animals

    The FDA has issued its final guidance on regulating genetically engineered (GE) animals under the new animal drug provisions of the Food, Drug and Cosmetic Act. The guidance clarifies FDA’s regulatory authority “and provides recommendations to producers of GE animals to help them meet their obligations and responsibilities under the law.” It is intended to…

  • New Administration Puts Freeze on COOL Regulations

    Among the first official acts of the Obama administration was a directive from White House Chief of Staff Rahm Emanuel to all federal departments and agencies not to finalize any pending rule and to extend final-rule effective dates for 60 days. According to a news source, the block affects a Department of Agriculture rule that…